The National Cancer Institute provides salary support and career stability for clinician scientists who lead and support its clinical trials networks without serving as research project grant principal investigators.
Funder: National Institutes of Health
Due Dates: February 17, 2027 (Applications) | February 17, 2028 (Applications) | February 20, 2029 (Applications)
Funding Amounts: Salary support for 2.4–4.8 person-months annually, plus up to $2,500 annual travel, for up to 5 years
Summary: Supports stable research careers for clinician scientists providing leadership and service within NCI-funded cancer clinical trials networks.
Key Information: Applicants must hold full-time positions and be more than six years beyond their initial faculty appointment.
The National Cancer Institute (NCI), part of NIH, offers this R50 award to sustain careers for exceptional clinician scientists supporting NCI-funded cancer clinical trials. It supports leadership in developing national trials, implementing trials at participating institutions, and serving on scientific review, monitoring, and network committees. The award provides salary support and autonomy for researchers who want to continue these contributions rather than serve as principal investigators of independent research project grants.
The program recognizes clinical trials work that often lacks dedicated reimbursement, including protocol development, patient recruitment, institutional oversight, and national network service. It targets clinicians with demonstrated productivity and research excellence at academic medical centers or NCORP community sites. Although recipients support existing clinical trials networks, applications under this opportunity may not propose clinical trials.